Data compiled by Redley Lamar · ChainSifter Intelligence
6Suppliers
11Customers
2Debt Items
20Related Chains
Source-Backed Evidence Depth
Journey Medical Corporation (DERM) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
20Total relationships
2Distinct source URLs
5High confidence
0.751Average confidence
2026-09-13Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
Reciprocal relationship from FBIO graph: Reciprocal relationship from DERM graph: Reciprocal relationship from FBIO graph: The Amendment amended the financial covenant requiring that product net sale…
t of assets, we currently, and will continue to, secure manufacturing agreements with either a counterparty to a transaction, with one or more of our contract manufacturers or additional contract man…
Reciprocal relationship from ORANY graph: Reciprocal relationship from DERM graph: t of assets, we currently, and will continue to, secure manufacturing agreements with either a counterparty to a tra…
Reciprocal relationship from RDY graph: Reciprocal relationship from DERM graph: Reciprocal relationship from RDY graph: Reciprocal relationship from DERM graph: Reciprocal relationship from RDY grap…
er serious labor problems that have materially impeded our business operations. Our human capital management objectives include, as applicable, identifying, recruiting, retaining, incentivizing, and …
Reciprocal relationship from VYNE graph: Reciprocal relationship from DERM graph: Reciprocal relationship from VYNE graph: Reciprocal relationship from DERM graph: Reciprocal relationship from VYNE g…
Journey Medical Corporation Customers
Ticker
Name
Confidence
Evidence
CUTIA
CUTIA
92%
Other revenue for the three-month period ended March 31, 2026 reflects sales-based royalties earned on the net sales of Amzeeq by Cutia.
NOTE 1. ORGANIZATION AND PLAN OF BUSINESS OPERATIONS Journey Medical Corporation (“Journey” or the “Company”) is a commercial-stage pharmaceutical company that primarily focuses on the selling and ma…
Reciprocal relationship from FBIO graph: Reciprocal relationship from DERM graph: Reciprocal relationship from FBIO graph: Reciprocal relationship from DERM graph: Reciprocal relationship from FBIO g…
Reciprocal relationship from ORANY graph: Reciprocal relationship from DERM graph: Reciprocal relationship from ORANY graph: Reciprocal relationship from DERM graph: t of assets, we currently, and wi…
t of assets, we currently, and will continue to, secure manufacturing agreements with either a counterparty to a transaction, with one or more of our contract manufacturers or additional contract man…
Reciprocal relationship from RDY graph: ell lung cancer following the results of the futility analysis. As a result, the Company recorded an impairment loss of Rs. 914 (U.S.$ 10 ) in the consolidated…
er serious labor problems that have materially impeded our business operations. Our human capital management objectives include, as applicable, identifying, recruiting, retaining, incentivizing, and …
Reciprocal relationship from VYNE graph: Reciprocal relationship from DERM graph: Reciprocal relationship from VYNE graph: Reciprocal relationship from DERM graph: er serious labor problems that have…
B-RILEY-SECURITIES-INC
B-RILEY-SECURITIES-INC
62%
6%, to $1.1 million for the three-month period ended March 31, 2026, from $1.1 million for the three-month period ended March 31, 2025, driven by the start of amortization on the anti-itch acquired i…
LAKE-STREET-CAPITAL-MARKETS-LLC
LAKE-STREET-CAPITAL-MARKETS-LLC
62%
6%, to $1.1 million for the three-month period ended March 31, 2026, from $1.1 million for the three-month period ended March 31, 2025, driven by the start of amortization on the anti-itch acquired i…
SWK-FUNDING-LLC
SWK-FUNDING-LLC
62%
NOTE 1. ORGANIZATION AND PLAN OF BUSINESS OPERATIONS Journey Medical Corporation (“Journey” or the “Company”) is a commercial-stage pharmaceutical company that primarily focuses on the selling and ma…
Journey Medical Corporation Debt Obligations
Instrument
Description
Confidence
Evidence
DERM-DEBT-9053
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2021-12-31.
DERM-DEBT
Debt stack $25.5M
90%
Market cache reports total debt of $25.5M.
Journey Medical Corporation Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Journey Medical Corporation.
Journey Medical Corporation Ownership
Holder
Name
Confidence
Evidence
DERM-OWNER-VANGUARD-CAPITAL-MANAGEMENT-LLC
VANGUARD CAPITAL MANAGEMENT LLC
90%
13F overlay lists VANGUARD CAPITAL MANAGEMENT LLC as top holder; 71 tracked holders.
Journey Medical Corporation Extended Supply Chain Network
